| PERIOD ENDING | 30-Sep-03 | 30-Jun-03 | 31-Mar-03 | | Total Revenue | 8,161 | 7,738 | 11,072 | | Cost of Revenue | 2,631 | 2,846 | 4,686 | | | Gross Profit | 5,530 | 4,892 | 6,386 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 4,622 | 4,572 | 4,740 | | Non Recurring | 1,092 |
-
| 1,061 | | Others | 513 | (54) | 81 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (697) | 374 | 504 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (878) | 2 | 2 | | Earnings Before Interest And Taxes | (1,575) | 376 | 506 | | Interest Expense | 714 | 1,497 | 1,699 | | Income Before Tax | (2,289) | (1,121) | (1,193) | | Income Tax Expense | (825) | 6 | 6 | | Minority Interest | 6 | 5 | 6 | | | | Net Income From Continuing Ops | (1,458) | (1,122) | (1,193) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,458) | (1,122) | (1,193) | | Preferred Stock And Other Adjustments | (517) | (494) | (486) | | | Net Income Applicable To Common Shares | ($1,975) | ($1,616) | ($1,679) |
|
0.20% Nasdaq 
Income Statement
